Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KangFuXin Ye for active gastric ulcer
ChiCTR1800016443Phase 4Recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of kangfuxin and esomeprazole in gastric ulcer (2 arms), sponsored by Liaocheng City People's Hospital. Primary endpoints: gastric ulcer stage and quality of ulcer healing. Started Jun 2018; status: recruiting.
02
Drugs
kangfuxinesomeprazole
03
Conditions
gastric ulcer
Beyond the preview
Go deeper on ChiCTR1800016443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016443.